Pulmonx Corporation Net Common Equity Issued/Repurchased 2019-2024 | LUNG
Pulmonx Corporation net common equity issued/repurchased from 2019 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
| Pulmonx Corporation Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2023 | $1 |
| 2022 | $3 |
| 2021 | $4 |
| 2020 | $206 |
| 2019 | $1 |
| 2018 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||